These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
415 related items for PubMed ID: 22752721
1. Genetic typing reveals monomorphism between antimony sensitive and resistant Leishmania donovani isolates from visceral leishmaniasis or post kala-azar dermal leishmaniasis cases in India. Subba Raju BV, Gurumurthy S, Kuhls K, Bhandari V, Schnonian G, Salotra P. Parasitol Res; 2012 Oct; 111(4):1559-68. PubMed ID: 22752721 [Abstract] [Full Text] [Related]
2. Antimony susceptible Leishmania donovani: evidence from in vitro drug susceptibility of parasites isolated from patients of post-kala-azar dermal leishmaniasis in pre- and post-miltefosine era. Ghosh S, Verma A, Kumar D, Deep DK, Ramesh V, Salotra P, Singh R. Microbiol Spectr; 2024 Jun 04; 12(6):e0402623. PubMed ID: 38712926 [Abstract] [Full Text] [Related]
3. Genetic markers for antimony resistant clinical isolates differentiation from Indian Kala-azar. Khanra S, Sarraf NR, Das S, Das AK, Roy S, Manna M. Acta Trop; 2016 Dec 04; 164():177-184. PubMed ID: 27629023 [Abstract] [Full Text] [Related]
4. Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India. Mandal S, Maharjan M, Singh S, Chatterjee M, Madhubala R. J Antimicrob Chemother; 2010 Mar 04; 65(3):496-507. PubMed ID: 20067981 [Abstract] [Full Text] [Related]
5. Genome wide comparison of Leishmania donovani strains from Indian visceral leishmaniasis and para-kala-azar dermal leishmaniasis patients. Sarraf NR, Mukhopadhyay S, Banerjee A, Das AK, Roy S, Chakrabarti S, Manna M, Saha P. Acta Trop; 2021 Nov 04; 223():106086. PubMed ID: 34389331 [Abstract] [Full Text] [Related]
6. Visceral leishmaniasis, or kala azar (KA): high incidence of refractoriness to antimony is contributed by anthroponotic transmission via post-KA dermal leishmaniasis. Singh R, Kumar D, Ramesh V, Negi NS, Singh S, Salotra P. J Infect Dis; 2006 Aug 01; 194(3):302-6. PubMed ID: 16826477 [Abstract] [Full Text] [Related]
7. Visceral and post-Kala-Azar dermal leishmaniasis isolates show significant difference in their in vitro drug susceptibility pattern. Mishra J, Madhubala R, Singh S. Parasitol Res; 2013 Mar 01; 112(3):1001-9. PubMed ID: 23242321 [Abstract] [Full Text] [Related]
9. Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani. Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, Sacks D. J Infect Dis; 1999 Aug 01; 180(2):564-7. PubMed ID: 10395884 [Abstract] [Full Text] [Related]
10. Drug susceptibility in Leishmania isolates following miltefosine treatment in cases of visceral leishmaniasis and post kala-azar dermal leishmaniasis. Bhandari V, Kulshrestha A, Deep DK, Stark O, Prajapati VK, Ramesh V, Sundar S, Schonian G, Dujardin JC, Salotra P. PLoS Negl Trop Dis; 2012 Aug 01; 6(5):e1657. PubMed ID: 22629478 [Abstract] [Full Text] [Related]
11. The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India. Singh N, Chatterjee M, Sundar S. Parasit Vectors; 2014 Dec 17; 7():596. PubMed ID: 25515494 [Abstract] [Full Text] [Related]
12. Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. Singh R, Kumar D, Duncan RC, Nakhasi HL, Salotra P. Int J Antimicrob Agents; 2010 Jul 17; 36(1):50-7. PubMed ID: 20427152 [Abstract] [Full Text] [Related]
13. Identification of genetic markers in sodium antimony gluconate (SAG) sensitive and resistant Indian clinical isolates of Leishmania donovani through amplified fragment length polymorphism (AFLP). Kumar A, Boggula VR, Sundar S, Shasany AK, Dube A. Acta Trop; 2009 Apr 17; 110(1):80-5. PubMed ID: 19283900 [Abstract] [Full Text] [Related]
14. DNA polymorphism assay distinguishes isolates of Leishmania donovani that cause kala-azar from those that cause post-kala-azar dermal Leishmaniasis in humans. Sreenivas G, Raju BV, Singh R, Selvapandiyan A, Duncan R, Sarkar D, Nakhasi HL, Salotra P. J Clin Microbiol; 2004 Apr 17; 42(4):1739-41. PubMed ID: 15071036 [Abstract] [Full Text] [Related]
15. The molecular characterization of clinical isolates from Indian Kala-azar patients by MLEE and RAPD-PCR. Manna M, Majumder HK, Sundar S, Bhaduri AN. Med Sci Monit; 2005 Jul 17; 11(7):BR220-7. PubMed ID: 15990683 [Abstract] [Full Text] [Related]
16. RFLPs of ITS, ITS1 and hsp70 amplicons and sequencing of ITS1 of recent clinical isolates of Kala-azar from India and Bangladesh confirms the association of L. tropica with the disease. Khanra S, Datta S, Mondal D, Saha P, Bandopadhyay SK, Roy S, Manna M. Acta Trop; 2012 Dec 17; 124(3):229-34. PubMed ID: 22960646 [Abstract] [Full Text] [Related]
17. Novel mechanism of drug resistance in kala azar field isolates. Singh N, Singh RT, Sundar S. J Infect Dis; 2003 Aug 15; 188(4):600-7. PubMed ID: 12898450 [Abstract] [Full Text] [Related]
18. Genetic fingerprinting and identification of differentially expressed genes in isolates of Leishmania donovani from Indian patients of post-kala-azar dermal leishmaniasis. Subba Raju BV, Singh R, Sreenivas G, Singh S, Salotra P. Parasitology; 2008 Jan 15; 135(Pt 1):23-32. PubMed ID: 17761024 [Abstract] [Full Text] [Related]
19. Multilocus microsatellite typing (MLMT) reveals genetic homogeneity of Leishmania donovani strains in the Indian subcontinent. Alam MZ, Kuhls K, Schweynoch C, Sundar S, Rijal S, Shamsuzzaman AK, Raju BV, Salotra P, Dujardin JC, Schönian G. Infect Genet Evol; 2009 Jan 15; 9(1):24-31. PubMed ID: 18957333 [Abstract] [Full Text] [Related]
20. Increased parasite surface antigen-2 expression in clinical isolates of Leishmania donovani augments antimony resistance. Bhandari V, Kumar D, Verma S, Srividya G, Negi NS, Singh R, Salotra P. Biochem Biophys Res Commun; 2013 Nov 01; 440(4):646-51. PubMed ID: 24103752 [Abstract] [Full Text] [Related] Page: [Next] [New Search]